PT Pyridam Farma Tbk (ISX:PYFA) Beta: 2.0840 (As of Jun. 28, 2026)


ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
68 GF Score
Price Rp184.00
GF Value Rp212.90
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Beta?

PT Pyridam Farma Tbk ISX:PYFA -4.66% 68 Beta is 2.0840 as of Jun. 28, 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 68/100 and a GF Value™ of Rp212.90 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), PT Pyridam Farma Tbk's Beta is 2.0840.


PT Pyridam Farma Tbk  (ISX:PYFA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


PT Pyridam Farma Tbk Beta Related Terms


PT Pyridam Farma Tbk Beta Historical Data

* Premium members only.

The historical data trend for PT Pyridam Farma Tbk's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Beta Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.90 1.27 0.52 2.09

PT Pyridam Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 0.75 2.22 2.09 2.10

ISX:PYFA vs ZTS, UTHR, VTRS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Pyridam Farma Tbk Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's Beta distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's Beta falls into.


ISX:PYFA
68GF Score
PT Pyridam Farma Tbk ISX:PYFA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Pyridam Farma Tbk Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.0840 mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Beta of 2.0840 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Pyridam Farma Tbk and its competitors.
Is PT Pyridam Farma Tbk's Beta too high?
PT Pyridam Farma Tbk's current Beta is 2.0840. Overall, PT Pyridam Farma Tbk has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Beta compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Beta of 2.0840 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Pyridam Farma Tbk and its competitors. PT Pyridam Farma Tbk's current Beta is 2.0840. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp212.90, compared to a current price of Rp184.00 — trading 13.6% below its estimated fair value. The current Beta is 2.0840. PT Pyridam Farma Tbk's overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Beta is 2.0840 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued. The current stock price of Rp184.00 is trading 13.6% below its estimated GF Value™ of Rp212.90. GuruFocus considers PT Pyridam Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:PYFA:

  • Beta: 2.0840
  • GF Value™: Rp212.90 vs. price of Rp184.00 (13.6% below fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
68GF Score

Get the complete analysis for ISX:PYFA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp184.00
Price
Rp212.90
GF Value